Navigation Links
AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
Date:4/20/2009

NEW YORK, April 8 /PRNewswire/ -- Adolescence is a challenging time that is full of changes, during which, some teenagers may experience a debilitating illness known as depression. The good news is that depression is treatable. Here's more about a treatment newly approved for adolescents dealing with depression.

Listen to this report from Forest Pharmaceuticals at:

http://inr.mediaseed.tv/oneClip_C/?feed=pBSDLDiuyUbscPNDurylRMlt_HeO_e9w

Registered journalists can access video, audio, text, graphics and photos for free and unrestricted use at http://www.mediaseed.tv.

04NY09-0075


'/>"/>
SOURCE Medialink; Forest Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. AUDIO from Medialink and Radica: Staying Sharp with Games for Your Brain
2. AUDIO from Medialink and Kelloggs: Whats in Your Water?
3. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
4. AUDIO from Medialink and Pfizer: Number of Uninsured Americans Grows to 47 Million
5. AUDIO from Medialink and Pfizer: Prescription for Safer Drugs Discussed in Washington
6. AUDIO from Medialink and Allergan: Women Not Sure Who to Trust on Anti-Aging Skin Care
7. AUDIO from Medialink and Pfizer: A New Prescription for Safer Drugs
8. Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues
9. AUDIO from Medialink and Kelloggs: The Jeans Dont Lie
10. AUDIO from Medialink and Bayer: Simple, Focused Ways to Boost Womens Health
11. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6Shanghai ChemPartner Is Pleased to be Part of Agios' Groundbreaking Cancer Research 2Giant Eagle(R) Pharmacy Receives Award for Operational Excellence 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U S Army Medical Research Institute of Infectious Diseases 14973 1Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U S Army Medical Research Institute of Infectious Diseases 14973 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 6522 1Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 6522 2Maryland Woman Thankful for Wyeth Verdicts 6518 1Maryland Woman Thankful for Wyeth Verdicts 6518 2